Nouri Alaleh 4

What Happened

• Nouri Alaleh, EVP, Chief Legal Officer & Corporate Secretary of PROCEPT BioRobotics (PRCT), sold 6,892 shares in an open-market transaction on 2026-03-06 at $23.70 per share for proceeds of $163,353.
• On 2026-03-05 Alaleh was also granted awards: 43,811 restricted stock units (RSUs) and 29,615 derivative shares (reported as an acquisition at $0.00). The awards were reported the same period as the sale.

Key Details

• Sale: 6,892 shares on 2026-03-06 at $23.70 — proceeds $163,353. (Footnote F2: sale made to cover tax withholding related to vesting of restricted awards.)
• Awards: 43,811 RSUs on 2026-03-05 (Footnote F1: RSUs — one-quarter vest on March 5, 2027; then one-sixteenth of the remaining RSUs vest quarterly over 36 months, subject to continued service).
• Derivative award: 29,615 shares reported as an acquisition on 2026-03-05 (Footnote F3: stock option vesting — 1/48th vests monthly from vesting commencement date of March 5, 2026 over four years, subject to continued service).
• Shares owned after the transactions: not specified in the filing.
• Filing date: Form 4 filed 2026-03-09 (transactions occurred 2026-03-05 and 2026-03-06). No 10b5-1 plan or late-filing designation is indicated in the provided footnotes.

Context

• The sale was disclosed as a tax-withholding sale tied to the vesting of restricted awards (routine administrative transaction), rather than a standalone discretionary sell for investment reasons.
• The awards are time-vesting (RSUs and option-like vesting) and do not represent an immediate purchase of free-and-clear shares until they vest; the derivative award vests monthly over four years.